Compass Therapeutics Inc. (CMPX)

AI Score

Unlock

2.13

0.06 (2.90%)

At close: Apr 24, 2025, 3:59 PM

2.12

-0.47%

Pre-market: Apr 25, 2025, 08:18 AM EDT

Compass Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018
Revenue	3.69M	3.69M	2.84M	2.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	931K	1.4M	1.87M	1.89M	1.91M	1.93M	1.95M	1.9M	1.82M	1.74M	1.65M	1.62M	1.23M	822K	413K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	2.76M	2.3M	972K	954K	-1.91M	-1.93M	-1.95M	-1.9M	-1.82M	-1.74M	-1.65M	-1.62M	-1.23M	-822K	-413K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-55.45M	-55.13M	-53.43M	-50.37M	-47.86M	-48.53M	-44.18M	-41.66M	-41.77M	-35.02M	-81.73M	-81.88M	-76.83M	-79.94M	-29.32M	-27.81M	-26.26M	-25.69M	-29.29M	-34.05M	-27.65M	-19.27M	-10.59M	n/a	n/a	n/a
Interest Income	5.71M	5.91M	6M	6M	5.32M	3.98M	2.34M	2.36M	1.07M	449K	34K	29K	43K	64K	62K	88K	166K	320K	550K	509K	413K	237K	n/a	n/a	n/a	n/a
Pretax Income	-47.76M	-47.24M	-45.44M	-42.49M	-40.67M	-42.68M	-39.9M	-39.23M	-40.63M	-34.63M	-81.92M	-82.18M	-77.58M	-80.75M	-30.5M	-29.47M	-27.68M	-27.05M	-30.3M	-34.65M	-28.05M	-19.52M	-10.74M	21.00	21.00	21.00
Net Income	-47.76M	-47.24M	-45.44M	-40.62M	-37.51M	-38.89M	-35.62M	-36.8M	-39.48M	-34.1M	-81.9M	-82.18M	-77.59M	-80.77M	-30.52M	-29.5M	-27.72M	-27.12M	-30.38M	-34.74M	-28.13M	-19.58M	-10.77M	n/a	n/a	n/a
Selling & General & Admin	13.95M	13.41M	11.81M	11.94M	12.24M	11.95M	11.96M	11.66M	12.13M	12.02M	11.06M	10.93M	11.04M	13.64M	13.55M	13.18M	12.73M	9.85M	11.05M	12.14M	9.04M	6.63M	3.35M	n/a	n/a	n/a
Research & Development	41.42M	41.64M	40.69M	37.96M	35.62M	36.58M	32.22M	30M	29.64M	23M	20.05M	20.34M	15.17M	15.69M	15.77M	14.63M	13.53M	15.84M	18.24M	21.91M	18.61M	12.63M	7.24M	n/a	n/a	n/a
Other Expenses	109K	109K	109K	n/a	1.87M	1.87M	1.87M	n/a	50.62M	50.57M	101.19M	101.19M	32.15M	23.25M	-27.37M	-29.6M	-11.18M	-2.23M	-2.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	55.37M	55.05M	52.49M	49.9M	47.86M	48.53M	44.18M	41.66M	41.77M	35.02M	31.11M	31.27M	26.21M	29.32M	29.32M	27.81M	26.26M	25.69M	29.29M	34.12M	27.71M	19.33M	10.66M	n/a	n/a	n/a
Interest Expense	1.87M	1.87M	1.87M	1.87M	1.29M	1.92M	2.34M	2.36M	1.11M	561K	248K	370K	509K	643K	774K	908K	1.01M	1.11M	1.19M	913.28K	629.28K	317.28K	3.28K	n/a	n/a	n/a
Selling & Marketing Expenses	-616K	-616K	-616K	-307K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	56.3M	55.98M	53.43M	50.37M	47.86M	48.53M	44.18M	41.66M	41.77M	35.02M	31.11M	31.27M	26.21M	29.32M	29.32M	27.81M	26.26M	25.69M	29.29M	34.12M	27.71M	19.33M	10.66M	n/a	n/a	n/a
Income Tax Expense	2.29M	2.8M	3.15M	858.5K	-2.31M	-3.44M	-4.28M	-2.43M	-1.15M	-492K	14K	176K	367K	545K	548K	422K	254K	68K	78K	91K	81K	55K	29.02K	21.00	21.00	21.00
Shares Outstanding (Basic)	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M	51.91M	51.31M	61.12M	61.12M	52.11M	52.11M	61.12M	52.11M	52.11M	5M	n/a	n/a	n/a
Shares Outstanding (Diluted)	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M	51.91M	51.31M	61.12M	61.12M	52.11M	52.11M	61.12M	52.11M	52.11M	5M	n/a	n/a	n/a
EPS (Basic)	-0.36	-0.36	-0.36	-0.32	-0.31	-0.34	-0.33	-0.36	-0.51	-0.5	-1.49	-1.56	-1.45	-1.5	-0.54	-0.52	-0.49	-0.5	-0.56	-2.59	-2.48	-2.32	-2.15	n/a	n/a	n/a
EPS (Diluted)	-0.36	-0.36	-0.36	-0.32	-0.31	-0.34	-0.33	-0.36	-0.51	-0.5	-1.49	-1.56	-1.45	-1.5	-0.54	-0.52	-0.49	-0.5	-0.56	-2.59	-2.48	-2.32	-2.15	n/a	n/a	n/a
EBITDA	-53.59M	-53.27M	-51.55M	-48.48M	-44.66M	-44.69M	-39.89M	-37.39M	-38.88M	-32.88M	-29.47M	-29.66M	-23.92M	-26.93M	-26.9M	-25.32M	-24.24M	-23.41M	-27.22M	-31.96M	-26.17M	-18.5M	-10.07M	n/a	n/a	n/a
EBIT	-27.28M	-15.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.86M	1.86M	1.87M	1.89M	1.91M	1.93M	1.95M	1.9M	1.82M	1.74M	1.65M	1.62M	2.3M	2.33M	2.35M	2.4M	1.86M	1.96M	2.06M	2.12M	1.6M	1.06M	526K	n/a	n/a	n/a